In the current study, we decipher the function of CD276 by genetic ablation and following single cell transcriptome analysis in murine BLCA model, which help to elucidate role of CD276 in cancer immune responses and provide evidence of synergistic anti-tumor effect of CD276 and PD-L1 blockade in cancer treatment. The gene discussed is CD276; the disease is bladder transitional cell carcinoma.